These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 28924872)

  • 1. [Alzheimer's disease from Auguste Deter to the present : Progress, disappointments and open questions].
    Pantel J
    Z Gerontol Geriatr; 2017 Oct; 50(7):576-587. PubMed ID: 28924872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alzheimer's disease (AD) therapeutics - 2: Beyond amyloid - Re-defining AD and its causality to discover effective therapeutics.
    Mullane K; Williams M
    Biochem Pharmacol; 2018 Dec; 158():376-401. PubMed ID: 30273552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The past, present, and future of disease-modifying therapies for Alzheimer's disease.
    Suzuki K; Iwata A; Iwatsubo T
    Proc Jpn Acad Ser B Phys Biol Sci; 2017; 93(10):757-771. PubMed ID: 29225305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of biomarkers to chart all Alzheimer's disease stages: the royal road to cutting the therapeutic Gordian Knot.
    Hampel H; Lista S; Khachaturian ZS
    Alzheimers Dement; 2012 Jul; 8(4):312-36. PubMed ID: 22748938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alzheimer's disease.
    De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
    Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emerging treatments for Alzheimer's disease for non-amyloid and non-tau targets.
    Khan A; Corbett A; Ballard C
    Expert Rev Neurother; 2017 Jul; 17(7):683-695. PubMed ID: 28490260
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunotherapy for Alzheimer's disease: from anti-β-amyloid to tau-based immunization strategies.
    Panza F; Frisardi V; Solfrizzi V; Imbimbo BP; Logroscino G; Santamato A; Greco A; Seripa D; Pilotto A
    Immunotherapy; 2012 Feb; 4(2):213-38. PubMed ID: 22339463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is aging part of Alzheimer's disease, or is Alzheimer's disease part of aging?
    Swerdlow RH
    Neurobiol Aging; 2007 Oct; 28(10):1465-80. PubMed ID: 16876913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perspective on future role of biological markers in clinical therapy trials of Alzheimer's disease: a long-range point of view beyond 2020.
    Hampel H; Lista S; Teipel SJ; Garaci F; Nisticò R; Blennow K; Zetterberg H; Bertram L; Duyckaerts C; Bakardjian H; Drzezga A; Colliot O; Epelbaum S; Broich K; Lehéricy S; Brice A; Khachaturian ZS; Aisen PS; Dubois B
    Biochem Pharmacol; 2014 Apr; 88(4):426-49. PubMed ID: 24275164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beyond Amyloid - Widening the View on Alzheimer's Disease.
    Behl C; Ziegler C
    J Neurochem; 2017 Nov; 143(4):394-395. PubMed ID: 29052848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Core biological marker candidates of Alzheimer's disease - perspectives for diagnosis, prediction of outcome and reflection of biological activity.
    Hampel H; Mitchell A; Blennow K; Frank RA; Brettschneider S; Weller L; Möller HJ
    J Neural Transm (Vienna); 2004 Mar; 111(3):247-72. PubMed ID: 14991453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cerebrospinal Fluid Biomarkers for Early and Differential Alzheimer's Disease Diagnosis.
    Bjerke M; Engelborghs S
    J Alzheimers Dis; 2018; 62(3):1199-1209. PubMed ID: 29562530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amyloid β oligomers in Alzheimer's disease pathogenesis, treatment, and diagnosis.
    Viola KL; Klein WL
    Acta Neuropathol; 2015 Feb; 129(2):183-206. PubMed ID: 25604547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The future of Alzheimer's disease: the next 10 years.
    Hampel H; Prvulovic D; Teipel S; Jessen F; Luckhaus C; Frölich L; Riepe MW; Dodel R; Leyhe T; Bertram L; Hoffmann W; Faltraco F;
    Prog Neurobiol; 2011 Dec; 95(4):718-28. PubMed ID: 22137045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Applied multimodal diagnostics in a case of presenile dementia.
    Schönecker S; Brendel M; Huber M; Vollmar C; Huppertz HJ; Teipel S; Okamura N; Levin J; Rominger A; Danek A
    BMC Neurol; 2016 Aug; 16():131. PubMed ID: 27506761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current pharmacotherapy and putative disease-modifying therapy for Alzheimer's disease.
    Kulshreshtha A; Piplani P
    Neurol Sci; 2016 Sep; 37(9):1403-35. PubMed ID: 27250365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detecting Alzheimer's disease biomarkers: From antibodies to new bio-mimetic receptors and their application to established and emerging bioanalytical platforms - A critical review.
    Scarano S; Lisi S; Ravelet C; Peyrin E; Minunni M
    Anal Chim Acta; 2016 Oct; 940():21-37. PubMed ID: 27662756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alzheimer's therapeutics: continued clinical failures question the validity of the amyloid hypothesis-but what lies beyond?
    Mullane K; Williams M
    Biochem Pharmacol; 2013 Feb; 85(3):289-305. PubMed ID: 23178653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Avicenna (980-1037 CE) and his Early Description and Classification of Dementia.
    Taheri-Targhi S; Gjedde A; Araj-Khodaei M; Rikhtegar R; Parsian Z; Zarrintan S; Torbati M; Vafaee MS
    J Alzheimers Dis; 2019; 71(4):1093-1098. PubMed ID: 31524162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The amyloid cascade hypothesis: are we poised for success or failure?
    Karran E; De Strooper B
    J Neurochem; 2016 Oct; 139 Suppl 2():237-252. PubMed ID: 27255958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.